In Brief: CellPro
This article was originally published in The Gray Sheet
CellPro: Judge in the U.S. District Court for the District of Delaware calls for a new trial in a patent suit filed against the firm by Baxter Healthcare, Becton Dickinson, and The Johns Hopkins University. In August 1995, a jury found that the claims of patents referenced in the suit were neither valid nor infringed. Plaintiffs in the case allege that CellPro's Ceprate SC stem cell concentration system and Ceprate LC laboratory cell separation system infringe four patents...
You may also be interested in...
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.